NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
12/08/2025
Voltar para busca
Dado oficial do USPTO
MMTS MULTI MINI TABLET SYSTEM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MMTS MULTI MINI TABLET SYSTEM
ST13
US500000097689880Classe
5, 40, 42
Pedido
97689880
Registro
7683627
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
12/08/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 40, 42
Data de depósito
23/11/2022
Data de registro
11/02/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/02/2025
Última transação
12/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Pessano con Bornago, IT
Examinador
SPARACINO, MARK
Localização atual
Historical data usage
Titulares e representantes
Titulares
ADARE PHARMACEUTICALS s.r.l.
Representantes
Robert S. Broder Collard & Roe, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary pharmaceutical preparationsin particular drug delivery compositionsdrug carriers and drug delivery agentscapsulessachets and sprinkles for pharmaceutical purposescomprising multiparticulates or multiple unitsused for the treatment of disorders or diseases in the gastrointestinal tractin the digestive systemin the gutin the immune systemsin the cardiovascular systemin the respiratory tractin the bloodin the metabolismin the nervous systemin the cognitionin the behaviorin the reproductive tractgastrointestinal infectionsdiarrheairritable bowel syndromeinflammatory bowel syndrome diseaseenterocolitisenteritisulcerative colitiscardiovascular disordershypertensionthrombosisvasoconstrictionasthmainflammation of respiratory tractasthmabronchoconstrictionthrombonemiaipertriglyceremiaipercholesterolemiaiperlipoproteinemia* thrombocythemiahypertriglyceridemiahypercholesterolemiahyperlipoproteinemia* blood anemiahypocalcemiadiabetesdiabetic peripheral neuropathydyskinesiahyperkinetic movementsenzyme deficiencypancreatitispancreatectomysteatorrheacystic fibrosisPaget's diseasebacterial infectionsviral infectionsfungal infectionsosteoporosiscancermucosal and systemic inflammationfunctional diseaseabdominal painallergyobesitymuscle spasticityspasmsconvulsiondysthymiaschizophreniadegenerative dementiaAlzheimer* Alzheimer's* stressanxietydepressionmood disturbancesociability disturbancesleep disturbancepsychological disturbanceattention deficit hyperactivity disorderaddictionfibromyalgiaobsessive-compulsive disorderspainperipheral neuropathic painpost-surgical painback-painosteoarthritis
Classe 40
Manufacturing services to the specification of others in the pharmaceutical field and in the veterinary fieldin particular in the field of pharmaceutical active substance delivery systemsincluding customized releasetaste masked releaseimmediate releasepulsatile releaseextended releasesustained releasedelayed release systems; clinical manufacturing of drug compositions for others to support clinical trials; manufacturing process consulting services for others relating to technology scale-up and integration of technology into manufacturing processes
Classe 42
Research and development services in the pharmaceutical field and in the veterinary fieldin particular in the field of pharmaceutical active substance delivery systems; research and development services for the preparation of multiparticulates or multiple units dosage forms including capsulessachetssprinkles; research and development in the area of delivery systems with customized releasetaste masked releaseimmediate releasepulsatile releaseextended releasesustained releasedelayed release; scientific research and development in the area of stability testingphysical characterizationin-vitro release testing
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
24/07/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14/07/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
18/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/02/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/02/2025
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
22/01/2025
IUCN
NOTICE OF ALLOWANCE CANCELLED
22/01/2025
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
09/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/12/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/12/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/06/2024
PUBO
PUBLISHED FOR OPPOSITION
11/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/05/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
06/05/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/05/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
06/05/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2024
ALIE
ASSIGNED TO LIE
02/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2023
GNRT
NON-FINAL ACTION E-MAILED
12/09/2023
CNRT
NON-FINAL ACTION WRITTEN
12/09/2023
DOCK
ASSIGNED TO EXAMINER
06/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/12/2022
NWAP
NEW APPLICATION ENTERED
26/11/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MMTS MULTI MINI TABLET SYSTEM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.